Immuno-oncology

Scroll to explore

Scroll back top

9 February 2023

PAR2 antagonist (DT-9045)

A2aR/A2bR antagonist (M1069)

EP4 receptor antagonist (DT-9081)

Anti-CCR8 antibody (DT-7012)

26 February 2020

Undisclosed GPCR targets